Introduction
============

*Aspergillus* causes a variety of clinical syndromes in the lung, such as aspergilloma, chronic necrotizing pulmonary aspergillosis (CNPA), invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis \[[@B1]\]. Aspergilloma occurs in patients with lung cavities, CNPA occurs in those who are mildly immunocompromised and invasive pulmonary aspergillosis is seen in patients who are immunocompromised, such as those with leukemia. We report a case of an older woman with a tumor-like shadow in her chest roentgenogram, which developed into disseminated invasive aspergillosis after 10 months of follow-up.

Case presentation
=================

An 80-year-old Japanese woman, without any relevant medical history, was referred to our hospital for a chest roentgenogram abnormality. Her chest roentgenogram and computed tomography (CT) results revealed tumor-like shadows, one of which was 35mm in diameter with a clear margin (Figure [1](#F1){ref-type="fig"}). It did not have a halo sign. F-fluorodeoxyglucose (FDG) positron emission tomography showed strong accumulation of glucose in tumor-like lesions (standardized uptake values (SUVs) of 8.53 and 21.1; Figure [2](#F2){ref-type="fig"}). She underwent two fiber-optic bronchoscopy examinations. However, the endobronchial biopsy specimen could not confirm any definite diagnosis. Owing to her age, further aggressive examination was not performed and she was followed-up as having suspected lung cancer. Her lung lesions gradually developed, which was compatible with lung cancer progression. Her general condition was well and there was no sign of infectious disease. Then, 10 months after her first visit, she complained of visual disturbance and eye pain, and was admitted to the department of ophthalmology of our hospital. Her clinical findings revealed endophthalmitis, but its etiology was unknown. She was treated with corticosteroids urgently for her rapidly progressing eye symptoms. She was administered fluconazole because systemic examination revealed esophageal candidiasis. At 20 days after admission, she developed acute encephalitis and was transferred to our department. Her serum level of β-[d]{.smallcaps} glucan was high (1184pg/mL) and a test result for *Aspergillus* antigen was positive. She was diagnosed as having invasive aspergillosis at this time and treated with micafungin followed by voriconazole. She died four weeks after the onset of encephalitis.

![**Chest imaging findings. (A)** Posterior anterior view of the chest roentgenogram showing the left hilar and para-aortic tumor-like shadows. **(B)** Chest computed tomography (CT) imaging showing the tumor-like shadow surrounding the left lower bronchus.](1752-1947-6-270-1){#F1}

![Positron emission tomography (PET) imaging showing the uptake of FDG at the lower and upper lesions in the left lung.](1752-1947-6-270-2){#F2}

An autopsy was performed after her death with her relatives' consent. The primary lesion of the lung consisted of fungus hyphae characteristic of *Aspergillus*. Inflammatory cells such as lymphocytes, plasma cells and eosinophils as well as granulation tissue surrounded the fungus lesion (Figure [3](#F3){ref-type="fig"}). A histologic examination of other organs including the cerebrum revealed that *Aspergillus* hyphae had disseminated throughout her body. The pathological diagnosis was disseminated invasive aspergillosis.

![**Histopathological findings. (A)** Collection of fungal hyphae surrounded by inflammatory cells and granulation tissue in the lung lesion; hematoxylin and eosin stain (×40). **(B)** Fungal hyphae stained by Groccot's stain (×200).](1752-1947-6-270-3){#F3}

Discussion
==========

The disease type associated with *Aspergillus* infection depends on the host's immunological status. Invasive pulmonary aspergillosis usually occurs in immunocompromised hosts, such as patients with leukemia, and is rapidly progressive \[[@B2]\]. The predisposing factors for CNPA development are mildly immunocompromised status or underlying lung diseases, such as chronic obstructive pulmonary disorder (COPD), inactive tuberculosis and pneumoconiosis \[[@B3],[@B4]\]. CNPA is usually a chronic, indolent and localized form of *Aspergillus* infection \[[@B5]\]. Our patient's case was compatible with this category, but was not typical in two regards. First, our patient did not have any underlying lung disease. Second, she developed disseminated fatal disease in the course of CNPA. We speculate that her age contributed to the disease. Cornet *et al*. reported two cases of fulminant invasive pulmonary aspergillosis in immunocompetent but older patients \[[@B6]\]. Two patients received short-term systemic corticosteroid therapy and their invasive aspergillosis progressed rapidly. The authors speculated that old age may have been a predisposing factor for the onset and rapidly fatal outcome of invasive aspergillosis. It should be highlighted that very old age might be a predisposing factor of CNPA. Two groups in Korea reported pulmonary aspergillosis in immunocompetent hosts without underlying lung disease \[[@B7],[@B8]\]. According to these authors, radiographic findings presented as a nodule or mass that could not be differentiated from malignancy on CT scan. Similarly, the radiographic findings in our patient's case mimicked lung cancer. The image of another case of invasive aspergillosis was also reported to mimic lung cancer \[[@B9]\]. Because lung cancer is far more prevalent than aspergillosis, the latter might be easily misdiagnosed as lung cancer. Because anti-fungal treatments have improved recently \[[@B10]\], an appropriate diagnosis and early treatment of CNPA are particularly important for a better outcome.

Conclusions
===========

A tumor-like shadow in a chest roentgenogram can be caused by CNPA in older people with no comorbidity. It should be borne in mind that very old age might itself be a predisposing factor for CNPA. Observation without appropriate treatment and even short-term corticosteroid therapy might lead to acute fatal disseminated aspergillosis. It is important to undertake careful examination and observation of undiagnosed pulmonary nodular or mass lesions because CNPA can be hidden in older patients.
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